As Congress moves toward possible approval of a new prescription drug program for Medicare recipients later this summer, how payments for cancer drugs and therapeutic services are determined may well hang in the balance.
Managing Office Politics and Clinical Negotiations With Neal Bhatia, MD
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
Equity Indexed Life Insurance Policies and Structured Notes: Asset Classes With Principal Protection and Growth Potential
How Physicians Can Find the Right Attorney
5 Simple Financial Tips for Dermatologists and Their Practices
Was It Marketing or Was It Misrepresentation?
2 Clarke Drive Cranbury, NJ 08512